Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Epidemiology
Published in: European Journal of Epidemiology 12/2015

Open Access 01-12-2015 | NEW STUDY

The French CONSTANCES population-based cohort: design, inclusion and follow-up

Authors: Marie Zins, Marcel Goldberg, CONSTANCES team

Published in: European Journal of Epidemiology | Issue 12/2015

Login to get access

Abstract

The CONSTANCES general-purpose cohort is intended to serve as an epidemiological research infrastructure accessible to the epidemiologic research community with a focus on occupational and social factors, and on chronic diseases and aging. CONSTANCES will also provide useful public health information to the public health authorities since it was designed as a large representative sample of the general French adult population. CONSTANCES is designed as a randomly selected representative sample of French adults aged 18–69 years at inception; 200,000 subjects will be included over a five-year period. At inclusion, the selected subjects are invited to complete questionnaires and to attend a Health Screening Center (HSC) for a comprehensive health examination. A biobank will be set up. The follow-up includes a yearly self-administered questionnaire, and a periodic visit to an HSC. Social and health data are collected from the French national databases. Data collected for participants include social and demographic characteristics, socioeconomic status, life events, behaviors, and occupational factors. The health data cover a wide spectrum: self-reported health scales, reported prevalent and incident diseases, long-term chronic diseases and hospitalizations, sick-leaves, handicaps, limitations, disabilities and injuries, healthcare utilization and services provided, and causes of death. To take into account non-participation at inclusion and attrition throughout the longitudinal follow-up, a cohort of non-participants was set up and will be followed through the same national databases as participants. Inclusion begun at the end of 2012 and more than 82,000 were already included by September 2015. A public call for nested research projects was launched.
Literature
1.
Burton PR, et al. Size matters: Just how big is BIG? Quantifying realistic sample size requirements for human genome epidemiology. Int J Epidemiol. 2009;38:263–73.PubMedPubMedCentralCrossRef
2.
Collins FS. The case for a US prospective cohort study of genes and environment. Nature. 2004;429:475–7.PubMedCrossRef
3.
Newton-Cheh C, et al. Eight blood pressure loci identified by genomewide association study of 34,433 people of European ancestry. Nat Genet. 2009;41:666–76.PubMedPubMedCentralCrossRef
4.
5.
Egan KM, Stampfe MJ, Hunter D, Hankinson S, Rosner BA, Holmes M, Willett WC, Colditz GA. Active and passive smoking in breast cancer: prospective results from the Nurses’ Health Study. Epidemiology. 2002;13:138–45.PubMedCrossRef
6.
Darling GM, Johns JA, McCloud PI, Davis SR. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women. N Engl J Med. 1998;338:64.CrossRef
7.
Collins R, UK Biobank Steering Committee. UK Biobank: protocol for a large-scale prospective epidemiological resource. Manchester: UK Biobank Coordinating Centre; 2007.
8.
Chen Z, Lee L, Chen J, Collins R, Wu F, Guo Y, Linksted P, Peto R. Cohort profile: the Kadoorie study of chronic disease in China (KSCDC). Int J Epidemiol. 2005;34:1243–9.PubMedCrossRef
9.
10.
Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondière UR, Hémon B, Casagrande C, Vignat J, Overvad K, Tjønneland A, Clavel-Chapelon F, Thiébaut A, Wahrendorf J, Boeing H, Trichopoulos D, Trichopoulou A, Vineis P, Palli D, Bueno-De-Mesquita HB, Peeters PH, Lund E, Engeset D, González CA, Barricarte A, Berglund G, Hallmans G, Day NE, Key TJ, Kaaks R, Saracci R. European prospective investigation into cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5:1113–24.PubMedCrossRef
11.
Stolk RP, Rosmalen JG, Postma DS, de Boer RA, Navis G, Slaets JP, Ormel J, Wolffenbuttel BH. Universal risk factors for multifactorial diseases: lifeLines: a three-generation population-based study. Eur J Epidemiol. 2008;23(1):67–74.PubMedCrossRef
12.
German National Cohort (GNC) Consortium. The German National Cohort: aims, study design and organization. Eur J Epidemiol. 2014;29:371–82.CrossRef
13.
14.
15.
16.
Goldberg M, Leclerc A, Bonenfant S, Chastang JF, Schmaus A, Kaniewski N, Zins M. Cohort profile: the GAZEL cohort study. Int J Epidemiol. 2007;36:32–9.PubMedPubMedCentralCrossRef
17.
Zins M, Leclerc A, Goldberg M. The French GAZEL cohort study: 20 years of epidemiologic research. Adv Life Course Res. 2009;14:135–46.CrossRef
18.
19.
Kilbom S, Armstrong T, Buckle P, Fine L, Hagberg M, Haring-Sweeney M, Martin B, Punnett L, Silverstein B, Sjøgaard G, Theorell T, Viikari-Juntura E. Musculoskeletal disorders: work-related risk factors and prevention. Int J Occup Environ Health. 1996;2(3):239–46.PubMedCrossRef
20.
Roche N, Dalmay F, Perez T, Kuntz C, Vergnenègre A, Neukirch F, Giordanella JP, Huchon G. Impact of chronic airflow obstruction in a working population. Eur Respir J. 2008;31:1227–33.PubMedCrossRef
21.
Brayne C. The elephant in the room—healthy brains in later life, epidemiology and public health. Nat Rev Neurosci. 2007;8(3):233–9.PubMedCrossRef
22.
Kivimaki M, Nyberg ST, Batty GD, Fransson EI, Heikkilä K, Alfredsson L, Bjorner JB, Borritz M, Burr H, Casini A, Clays E, De Bacquer D, Dragano N, Ferrie JE, Geuskens GA, Goldberg M, Hamer M, Hooftman WE, Houtman IL, Joensuu M, Jokela M, Kittel F, Knutsson A, Koskenvuo M, Koskinen A, Kouvonen A, Kumari M, Madsen IEH, Marmot MG, Nielsen ML, Nordin M, Oksanen T, Pentti J, Rugulies R, Salo P, Siegrist J, Singh-Manoux A, Suominen SB, Väänänen A, Vahtera J, Virtanen M, Westerholm PJM, Westerlund H, Zins M, Steptoe A, Theorell T, for the IPD-Work Consortium. Job strain as a risk factor for future coronary heart disease: collaborative analysis of 2358 events in 197,473 men and women. Lancet. 2012;. doi:10.​1016/​S0140-6736(12)60994-5.
23.
Niedhammer I, Goldberg M, Leclerc A, Bugel I, David S. Psychosocial factors at work and subsequent depressive symptoms in the GAZEL cohort. Scand J Work Environ Health. 1998;24:197–205.PubMedCrossRef
24.
Schuring M, Robroek SJ, Lingsma HF, Burdorf A. Educational differences in trajectories of self-rated health before, during, and after entering or leaving paid employment in the European workforce. Scand J Work Environ Health. 2015;. doi:10.​5271/​sjweh.​3514.PubMed
25.
Marmot M, et al. Closing the gap in a generation: health equity through action on the social determinants of health. Lancet. 2008;372:1661–9.PubMedCrossRef
26.
Dartigues JF, Alpérovitch A. Épidémiologie et vieillissement. In: Valleron AJ, editor. Épidémiologie: conditions de son développement, et rôle des mathématiques. Rapport sur la Science et la Technologie n° 23, Comité RST de l’Académie des sciences. Éditions EDP Sciences, 2006.
27.
28.
29.
Jagger C, Gillies C, Moscone F, Cambois E, Van Oyen H, Nusselder W, Robine JM, EHLEIS team. Inequalities in healthy life years in the 25 countries of the European Union in 2005: a cross-national meta-regression analysis. Lancet. 2008;372:2124–31.PubMedCrossRef
30.
31.
Remontet L, Buemi A, Velten M, Jougla E, Estève J. Évolution de l’incidence et de la mortalité par cancer en France de 1978 à 2000. InVS: Saint Maurice; 2002.
32.
ARME. Incidence et prévalence de différentes maladies. Bordeaux: ARME Pharmacovigilance; 2007.
33.
34.
Le Lenormand F. Système d’information de l’assurance maladie, le SNIIRAM et les échantillons de bénéficiaires. Courrier des statistiques. 2005;33:113–4.
35.
36.
37.
Févotte J, Dananché B, Delabre L, Ducamp S, Garras L, Houot M, Luce D, Orlowski E, Pilorget C, Lacourt A, Brochard P, Goldberg M, Imbernon E. MATGENE: a program to develop job-exposure matrices in the general population in France. Ann Occup Hyg. 2011;55:865–78.PubMedCrossRef
38.
39.
Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–86.PubMedCrossRef
40.
Folstein M, Anthony JC, Parhad I, Duffy B, Gruenberg EM. The meaning of cognitive impairment in the elderly. J Am Geriatr Soc. 1985;33:228–35.PubMedCrossRef
41.
Boll TJ, Reitan RM. Effect of age on performance of the Trail Making Test. Percept Mot Skills. 1973;36:691–4.PubMedCrossRef
42.
Miner T, Ferraro FR. The role of speed of processing, inhibitory mechanisms, and presentation order in trail-making test performance. Brain Cogn. 1998;38:246–53.PubMedCrossRef
43.
Wechsler D. Manual for the Wechsler Adulte Intelligence Scale—revised. New-York: Psychological Corporation; 1981.
44.
Mitrushina MN, Boone KB, D’Elia LF. Handbook of normative data for neuropsychological assessment. New York: Oxford University Press; 1999.
45.
Borkowski JG, Benton AL, Spreen O. Word fluency and brain damage. Neuropsychologica. 1967;5:135–40.CrossRef
46.
Cardebat D, Doyon B, Puel M, Goulet P, Joanette Y. Formal and semantic lexical evocation in normal subjects. Performance and dynamics of production as a function of sex, age and educational level. Acta Neurol Belg. 1990;90:207–17.PubMed
47.
Grober E, Buschke H, Crystal H, Bang S, Dresner R. Screening for dementia by memory testing. Neurology. 1988;38:900–3.PubMedCrossRef
48.
Van der Linden M, Coyette F, Poitrenaud J, Kalafat M, Calicis F, Wyns C, Adam S et les membres du GREMEM. L’épreuve de rappel libre/rappel indicé à 16 items (RL/RI-16). L’évaluation des troubles de la mémoire. Van der Linden M et les membres du GREMEM, editors. Solal Éditeur, Marseille, 2004.
49.
Shkuratova N, Morris ME, Huxham F. Effects of age on balance control during walking. Arch Phys Med Rehabil. 2004;85:582–8.PubMedCrossRef
50.
Horak FB, Shupert CL, Mirka A. Components of postural dyscontrol in the elderly: a review. Neurobiol Aging. 1989;10:727–38.PubMedCrossRef
51.
Giampaoli S, Ferrucci L, Cecchi F, LoNoce C, Poce A, Dima F, Santaquilani A, Vescio MF, Menotti A. Hand-grip strength predicts incident disability in non-disabled older men. Age Ageing. 1999;28:283–8.PubMedCrossRef
52.
Goldberg M, Luce D. Les effets de sélection dans les cohortes épidémiologiques. Nature, causes et conséquences. Rev Epidemiol Santé Publique. 2001;49:477–92.PubMed
53.
Groves RM. Nonresponse rates and nonresponse bias in household surveys. Public Opin Q. 2006;70:646–75.CrossRef
54.
Criqui MH. Response bias and risk ratios in epidemiologic studies. Am J Epidemiol. 1979;109:394–9.PubMed
55.
Austin MA, Criqui MH, Barrett-Connor E, Holdbrook MJ. The effect of response bias on the odds-ratio. Am J Epidemiol. 1981;1981(114):137–43.
56.
Groves RM, Peytcheva E. The impact of nonresponse rates on nonresponse bias. Public Opin Q. 2008;72:167–89.CrossRef
57.
Goldberg M, Chastang JF, Zins M, Niedhammer I, Leclerc A. Health problems were the strongest predictors of attrition during follow up of the GAZEL cohort. J Clin Epidemiol. 2006;59:1213–21.PubMedCrossRef
58.
Goldberg M, Chastang JF, Leclerc A, Zins M, Bonenfant S, Bugel I, Kaniewski N, Schmaus A, Niedhammer I, Piciotti M, Chevalier A, Godard C, Imbernon E. Socioeconomic, demographic, occupational and health factors associated with participation in a long-term epidemiologic survey. A prospective study of the French GAZEL cohort and its target population. Am J Epidemiol. 2001;154:373–84.PubMedCrossRef
59.
Vercambre MN, Gilbert F. Respondents in an epidemiologic survey had fewer psychotropic prescriptions than nonrespondents: an insight into health-related selection bias using routine health insurance data. J Clin Epidemiol. 2012;65:1181–9.PubMedCrossRef
60.
Institut de veille sanitaire. Estimation des taux de prévalence des anticorps anti-VHC et des marqueurs du virus de l’hépatite B chez les assurés sociaux du régime général de France métropolitaine, 2003–2004. Analyse descriptive. Saint Maurice: Institut de veille sanitaire; 2005.
61.
Santin G, Geoffroy B, Bénézet L, Delézire P, Chatelot J, Sitta R, Bouyer J, Gueguen A. SNIIRAM Cohorts Group. In an occupational health surveillance study, auxiliary data from administrative health and occupational databases effectively corrected for nonresponse. J Clin Epidemiol. 2014;67(6):722–30.PubMedCrossRef
62.
Zins M, Berkman LF, Goldberg M, The CONSTANCES team. The CONSTANCES cohort, an epidemiological research infrastructure. Methods and results of the pilot phase. Epidemiol Biostat Public Health. 2013;10:e8921-1. doi:10.​2427/​8921.
63.
Metadata
Title
The French CONSTANCES population-based cohort: design, inclusion and follow-up
Authors
Marie Zins
Marcel Goldberg
CONSTANCES team
Publication date
01-12-2015
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 12/2015
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-015-0096-4

Other articles of this Issue 12/2015

European Journal of Epidemiology 12/2015 Go to the issue

Letter to the Editor

Carbon monoxide exposure may underlie the increased leukaemia risk in children living next to motor highways

Editorial

A note of thanks

META-ANALYSIS

Risk for childhood leukemia associated with maternal and paternal age

CANCER

Childhood cancer and residential exposure to highways: a nationwide cohort study

STUDY UPDATE

The Rotterdam Scan Study: design update 2016 and main findings

LETTER TO THE EDITOR

Population mixing and childhood leukaemia